New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
Farrell
Geoffrey C
GC
D000998:Antiviral Agents / Q000627:therapeutic use*; D001208:Asia / Q000453:epidemiology; D001315:Australia / Q000453:epidemiology; D003140:Communicable Disease Control / Q000379:methods*; D006526:Hepatitis C / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007124:Immunoenzyme Techniques / Q000592:standards; D016898:Interferon-alpha / Q000627:therapeutic use; D025202:Molecular Diagnostic Techniques / Q000592:standards; D017410:Practice Guidelines as Topic; D011933:Reagent Kits, Diagnostic / Q000592:standards; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D011933:Reagent Kits, Diagnostic; D012254:Ribavirin